Therapeutic Implications of PPARγ in Human Osteosarcoma
Osteosarcoma (OS) is the most common nonhematologic malignancy of bone in children and adults. Although dysregulation of tumor suppressor genes and oncogenes, such as Rb, p53, and the genes critical to cell cycle control, genetic stability, and apoptosis have been identified in OS, consensus genetic...
Saved in:
Main Authors: | Eric R. Wagner, Bai-Cheng He, Liang Chen, Guo-Wei Zuo, Wenli Zhang, Qiong Shi, Qing Luo, Xiaoji Luo, Bo Liu, Jinyong Luo, Farbod Rastegar, Connie J. He, Yawen Hu, Barrett Boody, Hue H. Luu, Tong-Chuan He, Zhong-Liang Deng, Rex C. Haydon |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2010-01-01
|
Series: | PPAR Research |
Online Access: | http://dx.doi.org/10.1155/2010/956427 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Mesenchymal Progenitor Cells and Their Orthopedic Applications: Forging a Path towards Clinical Trials
by: Deana S. Shenaq, et al.
Published: (2010-01-01) -
Emerging PPARγ-Independent Role of PPARγ Ligands in Lung Diseases
by: Ajit A. Kulkarni, et al.
Published: (2012-01-01) -
PPARγ and PPARδ as Modulators of Neoplasia and Cell Fate
by: Robert I. Glazer, et al.
Published: (2008-01-01) -
PPARγ in Inflammatory Bowel Disease
by: Vito Annese, et al.
Published: (2012-01-01) -
PPARγ and Its Role in Cardiovascular Diseases
by: Mini Chandra, et al.
Published: (2017-01-01)